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The molecule Dimethyl sulfoxide is widely used as drug solvent. However, its antioxidant 27 
property was poorly explored. In this study, we evaluated the effect of DMSO 28 
supplementation during oocyte in vitro maturation (IVM) on embryo development and 29 
quality. Bovine oocytes were matured with different DMSO concentrations (0, 0.1, 0.25, 30 
0.5, 0.75, 1 and 10% v:v) followed by in vitro fertilization. Subsequently, quality indicators 31 
such as gene expression of SOX2, OCT4, CDX2, SOD1, oocyte and embryo redox status 32 
and DNA damage were evaluated. Polar body extrusion and blastocyst rates increased with 33 
0.5 % v:v DMSO. Moreover, first polar body extrusion and blastocyst rates did not increase 34 
with 1%, and 10% of DMSO reduced polar body extrusion and did not produce blastocyst. 35 
Optimal concentration of DMSO for the use on the maturation was estimated at around 36 
0.45% v:v. Supplementation with 0.5% v:v DMSO has not affected mRNA abundance of 37 
genes key in blastocyst, however 0.75% increased gene expression of OCT4 and SOX2. 38 
Oocytes matured with 0.5% v:v DMSO and blastocyst from DMSO group showed reduced 39 
lipid peroxidation respect control. Total Glutathione concentrations increased in blastocyst 40 
stage in DMSO group. DMSO increased the total cell number of blastocysts but not 41 
TUNEL positive cells. In conclusion, our results suggest that low DMSO concentrations 42 
used during bovine oocytes in vitro maturation increases the maturation, as well as the 43 
blastocyst rate and its quality, without demonstrating deleterious effect on embryo cells. 44 
Key words: cattle, embryo, oxidative stress 45 
1. Introduction 46 
Dimethyl sulfoxide (DMSO) is a small organic polar aprotic molecule used as 47 
cryoprotectant and solvent for some drugs due to its amphipathic nature [1, 4]. Besides, the 48 
pharmacological actions of DMSO have been evaluated by properties like membrane 49 
penetration, carrier effect, collagen deposition and ti-inflammatory activity, among others 50 
[1, 2, 3, 4].  51 
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In vitro production systems use DMSO to solute drugs like roscovitine [5]. However, due 52 
to possible cellular toxicity, this compound must be used in low concentrations [6, 7]. 53 
Nevertheless, it has been shown that DMSO, used in low doses, has antioxidant effects 54 
since inhibits endoperoxide biosynthesis [8] and neutralizes the cytotoxic effects of reactive 55 
oxygen species (ROS) [9, 10].  56 
ROS (superoxide anion radical O2-; hydrogen peroxide H2O2, and the hydroxyl radical    57 
HO-) are originated from normal cell metabolism, but its production is increased by 58 
external factors like oxygen tension [11]. The embryo has antioxidative mechanisms that 59 
counteract ROS action. However, protein, membrane ad DNA damage have been 60 
observed when this balance between ROS and antioxidant mechanisms is broken. 61 
Consequently, the embryo development decreases [12, 13, 14, 15, 16, 17, 18, 19].  62 
Nonetheless, the efficiency of in vitro embryo production increases when the oocytes are 63 
treated during in vitro maturation with antioxidants such as quercetin, vitam n C, 64 
resveratrol [20], melatonin [21] and glutathione (GSH) promoters as β-mercaptoethanol, 65 
cysteine and cystine [22]. The maturation process involves a number of events that gives 66 
oocyte the capacity for normal embryo development [23]. However, an antioxidant effect of 67 
low doses of DMSO on oocytes and embryonic development has not been explored yet. 68 
Considering the wide use of DMSO in vitro embryo production and its unexplored 69 
antioxidant property, this study evaluates the effect of DMSO supplementation at low 70 
concentrations on the maturation medium of oocyte over embryo development and quality.  71 
2. Materials and methods 72 
2.1. Experimental design  73 
2.1.1. First polar body extrusion and embryo development 74 
First, we determined the effect of DMSO on the extrusion of the first polar body (1PB) 75 
after IVM was determined. For this, five concentrations of DMSO were tested: 0, 0.1, 0.5, 1 76 
and 10% v:v DMSO (N: 241, 195, 142, 192, 172 oocytes r spectively). In all the 77 
repetitions, the IVM was performed in 35 mm dish with 3.5 ml of mineral oil (MO). 78 
Second, the effect of DMSO on cleavage and blastocy rates was evaluated (Figure 1). In 79 
this case the IVM medium was supplemented with 0, 0.1 .5, 1 or 10% v:v DMSO (N: 80 
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446, 322, 194, 250, 39 oocytes respectively). Concentration 0.25 and 0.75 % of DMSO 81 
were added to evaluation (N: 65 and 77) to calculate optimal dose.  82 
Blastocyst produced in this experiment were destined to gene expression analysis and DNA 83 
fragmentation and total cell number evaluation. According results obtained and for practical 84 
purposes, 0.5% v:v was used as the optimum dose in analyses below. 85 
2.1.2. Gene expression 86 
Expression level of OCT4, SOX2, CDX2 and SOD1 transcripts were evaluated in 87 
blastocysts from oocytes supplemented with 0, 0.5 and 0.75% v:v DMSO in the IVM 88 
medium obtained from 2.1.1. 89 
2.1.3. Redox balance 90 
Superoxide dismutase (SOD) activity, total content of GSH and lipid peroxidation were 91 
evaluated. For this, separately in specific repetitions, IVM medium was supplemented with 92 
0 and 0.5% v:v DMSO. Immature and mature cummulus oocytes complexes (COCs), 8/16 93 
cell embryos and blastocysts were compared separately according to each developmental 94 
stage. 95 
2.1.4. DNA fragmentation and total cell number 96 
Damage in DNA and total cell number were evaluated by TUNEL assay in blastocysts from 97 
0, 0.5 and 0.75% v:v DMSO group obtained from 2.1.1. 98 
2.2.Oocyte collection and in vitro maturation 99 
Ovaries were collected from slaughterhouse and transported to the laboratory. COCs were 100 
aspirated from small antral follicles (2-8 mm). COCs covered with at least 3 layers of 101 
granulosa cells were selected and maturated in vitro. Maturation medium was Tissue 102 
Culture Medium 199 (31100-035, Gibco, Grand Island, NY  USA) supplemented with 10% 103 
fetal bovine serum, 10 µg/mL follicle stimulating hormone (NIH-FSH-P1; Folltropin ®, 104 
Bioniche, Belleville, ON, Canada), 0.3 µM sodium pyruvate (P2256; Sigma-Aldich, St 105 
Louis, MO, USA), 100 µM cysteamine (M9768; Sigma-Aldich, St Louis, MO, USA), and 106 
2% antibiotic-antimycotic (15240-096; Gibco, Grand Island, NY, USA). The COCs were 107 
incubated in 100 ul droplets (20-25 oocytes/droplet) covered with mineral oil (0121-1; 108 
Fisher Chemical, Pittsburgh, PA, USA) for 24 hours at 6.5% CO2 in humidified air at 109 
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38.5°C. Different concentrations of DMSO (D2650; Sigma-Aldich, St Louis, MO, USA) 110 
were added to the maturation media, depending on the experiment. After IVM, COCs were 111 
vortexed for 2 min in hyaluronidase (H-4272; Sigma-Aldich, St Louis, MO, USA. 1 112 
mg/mL) in Dulbecco´s phosphate saline (to remove cumul s cells). First polar body 113 
extrusion was evaluated by direct observation on stereoscopic microscope (SMZ 800; 114 
Nikon, Tokio, Japón).  115 
2.3. In vitro fertilization and culture 116 
Frozen semen was thawed for 30 seconds by bain-marie at 37 °C. Then, spermatozoa were 117 
centrifuged twice (490 x g, 5 minutes) in Brackett & Oliphant (BO) medium [24], with 16 x 118 
106 spermatozoa/ml for 5 hours. Afterwards, presumptive zygotes were cultured in 119 
Synthetic Oviductal Fluid [25, 26] with 2.5% of fetal bovine serum for 7 days at 38.5°C 120 
and 5% O2. Cleavage and blastocyst rates were observed on days 2 nd 7, respectively. 121 
2.4.Gene expression analysis 122 
Three replicates of blastocysts (N5) treated with 0, 0.5 and 0.75% (v:v) DMSO were 123 
analyzed. The expression of OCT4, SOX2, CDX2 AND SOD1 genes was evaluated. 124 
Embryos were stored in RNAlater at -20°C until gene xpression analysis. Embryos were 125 
treated with a Cells-to-cDNA TM II kit (Ambion Co., Austin, TX, USA) lyses buffer 126 
according to manufacturer’s instruction. Briefly, embryos were washed twice in cold PBS 127 
to eliminate the RNAlater; 30 µl of lysis buffer was added and incubated 10 minutes at 128 
75°C. All samples were treated with DNase I (0.04 U/µl) for genomic DNA digestion. For 129 
cDNA conversion, 10 µl of total RNA was used in a 20µl final reaction containing 5 µM 130 
random primers, 10 mM each dNTP, 2 µl first strand buffer (10×), 10 U of RNase inhibitor, 131 
and 200 U/ml M-MuLV (Ambion Co., Austin, TX, USA). Cycling parameters were: 70°C 132 
for 3 minutes, 42°C for 60 minutes, and 92°C for 10 minutes. The produced cDNAs were 133 
kept frozen at −20°C until use in PCR experiments. 134 
Gene expression analysis was performed by real-time qPCR using the standard curve 135 
method. The standard curve was performed using 2 µl of PCR products for each gene, 136 
previously purified from agarose gel and eluted using the E.Z.N.A gel extraction kit 137 
(Omega, Biotek, Santiago, Chile) and quantified using a spectrophotometer (Epoch, BioTek 138 
Instruments, Inc., Winooski, VT, USA). Eight points of serial ten-fold dilutions of PCR 139 
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products were included in each standard curve, and 2 µl was used in duplicate for each 140 
point. For qPCR analysis, samples were loaded in duplicate (technical replicates). The 141 
qPCR reactions were made with 2 µl of cDNA from each sample, 1 µl of primers (10 pmol 142 
each, forward and reverse), 5 µl of 2x SensimixTM SYBR® Hi-ROX (Bioline, Berlin, B, 143 
Germany), in a final volume of 10 µl. The reaction was run on a MX3000P Real-Time PCR 144 
device (Agilent, Santa Clara, CA, USA). Melting curves (CP) and threshold values were 145 
calculated with built-in software for all the runs. The expression of each gene was 146 
normalized in relation to the expression of ACTB. Only PCR experiments with an 147 
efficiency within the range of 90% to 110% and a correlation coefficient of at least 0.9 148 
were used for gene expression analysis. Similarly, only samples within the quantification 149 
range of the standard curve were considered for the analysis. The primers used and PCR 150 
conditions for each gene are presented in Table 1. 151 
2.5.Redox balance  152 
For each replicate, groups of COCs (10) and 8/16 cells embryos (10), and  blastocyst (5), 153 
were homogenized in microtubes containing 100 µl Tris Base Buffer 20 mM, pH=7.6 with 154 
a Teflon-glass homogenizer in ice. The suspension was centrifuged at 4500 X g for 10 155 
minutes at 4ºC. The supernatant was saved and stored at –80ºC until use. We have 156 
optimized the redox balance tests using a minimum amount of sample and reagents. This 157 
allowed us to carry out a greater number of replicates in each test and perform multiple 158 
evaluations from the same group of COCs/embryos. This was possible using a microplate 159 
reader and 96-well plates. The Biochrom EZ Read 400 Microplate Reader and Galapagos 160 
for EZ Read Software (Biochrom Ltd., Cambridge, UK) were used. In this way, we have 161 
made evaluations of: protein concentration, SOD activity, total glutathione concentration 162 
and lipid peroxidation [27].  163 
Protein concentration 164 
The concentration of proteins was determined in each group by the Bradford method 165 
adapted to microplate. A curve of known concentrations of albumin was used as a 166 
reference. Absorbance of 10 µl of sample and 100 µl of Bradford's reagent was read at 595 167 
nm. 168 
Lipid peroxidation 169 
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TBA reactive species (TBA-RS) method was used for the evaluation of the amount of 170 
malondialdehyde (MDA) formed from the breakdown of polyunsaturated fatty acids. 171 
Briefly, homogenate 30 µl was treated with trichloroacetic acid (TCA) 15% (w/v)- 172 
thiobarbituric acid (TBA) 0.375% (w/v)- HCI 0.25M in microtubes and heated for 15 173 
minutes in water at 100ºC. After cooling, the absorance of samples was registered at 492 174 
nm. Lipid peroxidation was expressed as nmol MDA/unit (COCs/embryo). 175 
Total Glutathione concentration 176 
The measurement of acid-soluble thiol was used for estimating GSH content. Phosphate 177 
buffer (pH= 7) containing NADPH (N7505; Sigma-Aldich, St Louis, MO, USA) and GSH 178 
reductase (G3664; Sigma-Aldich, St Louis, MO, USA) incubated 10 µl of homogenates. 179 
The enzymatic reduction of GSSG to GSH was analyzed with Ellman’s reagent (D8130; 180 
DTNB, Sigma and Co, St Louis, MO, USA) in a kinetic measurement for 5 minutes using 181 
microplate reader at 405 nm. Blanks consisting of homogenizing buffer were used instead 182 
of samples. Results were expressed as pmol GSH/ug protein.  183 
 Superoxide dismutase (SOD) 184 
The RX MONZA - RANSOD - SD 125 kit was used, which employs xanthine and xanthine 185 
oxidase (XOD) to generate superoxide radicals that re ct with 2-(4-iodophenyl)-3-(4-186 
nitrophenol)-5-phenyltetrazolium chloride (INT) to form a red formazan dye. The 187 
superoxide dismutase activity is then measured by the degree of inhibition of this reaction. 188 
One unit of SOD causes a 50% inhibition of the rateof reduction of INT at the conditions 189 
of the assay. The sample and reagent volumes were adapted to microplate, using one tenth 190 
of the volumes indicated in the kit. Absorbance was read at 492 nm, performing a kinetic 191 
measurement according to the manufacturer's instructions, reading initial absorbance after 192 
30 seconds of mixing the reagents and final absorbance after 3 minutes. Results were 193 
expressed as USOD/mg protein.  194 
2.6. DNA damage and total cell number  195 
DNA fragmentation was evaluated with a commercial kit (DeadEnd™ Fluorometric 196 
TUNEL System, Promega, Madison, WI, USA). Blastocysts derived from 0, 0.5 and 0.75% 197 
DMSO treatments (N=7, 7 and 14 respectively) were fix d in 4% paraformaldehyde 198 
solution. Labelling was performed according to the manufacturer's instruction. The 199 
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embryos were mounted on slides using commercial mounting medium (Vectashield, Vector 200 
Laboratories, Burlingame, CA, USA) and examined with confocal fluorescence 201 
microscope. The images of each embryo were analyzed using Fiji Software [28].  202 
2.7.Statistical analysis 203 
At least three replicates were performed in each experiment. First, polar body extrusion, 204 
cleavage, blastocyst rates, and TUNEL+ cells were statistically analyzed using Chi square 205 
test. A quadratic regression model was fitted to blastocyst rates data and a dose-response 206 
curve was estimated by means of weighted least squares. Parametric results were tested for 207 
normality and results of SOX2, SOD1 mRNA abundance and MDA concentration were 208 
transformed to Log10. Differences in gene expression, t tal cell number and oxidative 209 
stress were calculated through ANOVA, means differences were tested by Tukey`s post 210 
hoc test.  211 
3. Results 212 
3.1.First polar extrusion  213 
The addition of 0.5 % DMSO increased first polar body extrusion rates. Nevertheless, 0.1 214 
and 1% DMSO resulted in a similar polar body extrusion rate with control group, while 215 
10% DMSO resulted in lower rates (p<0.05) (Table 2). 216 
3.2.Embryo development 217 
The addition of 0.1, 0.5 and 1% DMSO during in vitro maturation resulted in similar 218 
cleavage rates than with control group. In turn, the addition of 10% DMSO significantly 219 
decreased cleavage rates (p<0.05). On the other hand, blastocyst rates increased when IVM 220 
medium was supplemented with 0.5% DMSO, compared to control (p<0.05). Moreover, 221 
the addition of IVM with 10% DMSO failed in the development of blastocysts (Table 3). 222 
The R2 for the quadratic dose-response curve for blastocy rates was 0.43 and the 223 
regression coefficients were statistically significant (p<0.0001). Both 0.25 and 0.75% 224 
showed similar results to 0.5% v:v DMSO. 225 
According to the estimated curve, the maximum blastocyst rate is achieved when the 226 
concentration of DMSO in the maturation medium is around 0.45% v:v (Figure 2).  227 
Gene expression  228 
Revised 
Group 0.5 % DMSO showed similar mRNA abundance with control group. However, 229 
0.75% DMSO resulted in increased OCT4 and SOX2 abundance (p<0.05). The expression 230 
levels of CDX2 and SOD1 did not differ among treatments (Figure 3). 231 
3.3.Redox balance 232 
Lipid peroxidation: As shown in Figure 4, control matured COCs showed higher MDA 233 
concentration than immature COCs (p<0.05). On the ot r hand, DMSO matured group 234 
showed a decrease MDA compared to control (p<0.05). MDA concentration did not differ 235 
between DMSO matured and immature COCs. In 8/16 cell embryos, no differences among 236 
treatments were observed. Blastocysts from oocytes matured with DMSO showed less lipid 237 
peroxidation compared to control (p<0.05). 238 
Total GSH contents: Matured COCs showed lower GSH content than immature COCs 239 
(p<0.05). COCs treated with DMSO did not differ from control group. In 8/16 cell 240 
embryos, no differences among treatments were observed. Blastocyst from COCs treated 241 
with DMSO showed higher values of total GSH than cotrol group (p<0.05). 242 
SOD activity: The presence of DMSO in the maturation medium did not affect the activity 243 
of SOD enzyme. 244 
3.4.DNA damage and total cell number  245 
To evaluate the toxicity of DMSO, we analyzed the total number of cells and DNA 246 
fragmentation in blastocysts derived from 0, 0.5 and 0.75% DMSO matured oocytes. The 247 
number of blastocyst cells from DMSO treatments was higher than control. TUNEL 248 
positive cells did not differ among treatments (Figure 5 and Table 4).  249 
  250 
4. Discussion 251 
The present study showed that the use of low concentrations of DMSO in the maturation 252 
medium of cattle oocytes increases the rate of the blastocysts produced without apparent 253 
cell toxicity.  254 
A dose dependent effect of DMSO was observed in maturation and blastocyst rates. Results 255 
suggest that 0.5% DMSO in in vitro maturation medium increases 1PB extrusion rate, 256 
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while 10% DMSO has a detrimental effect, where embryo development failed. In 1% 257 
DMSO group, 1PB extrusion and cleavage rates did not differ compared to control. 258 
However, previous reports showed that over 1% DMSO has cellular toxic effect through 259 
alterations in the structure of plasma membrane, cytoplasm [29, 30], extrusion of 1PB [29], 260 
dysregulated gene expression and apoptosis [7]. In turn, blastocyst rate in 1% DMSO was 261 
similar to control group and it showed a quadratic response with an optimum at 0.45% v:v. 262 
This response is probably due a long-term effect of maturation on oocyte developmental 263 
since part of oocyte competence is acquired during this complex and dynamic process [32, 264 
33, 34, 35, 36, 37, 38, 39]. On the other hand, when similar doses of DMSO were used for a 265 
longer period, during the in vitro culture, effect on blastocyst rates was not observed [40, 266 
6]. Nevertheless, DMSO used during IVC in concentrations up to 0.25% showed alterations 267 
in key genes expression. Relative expression of pro ap ptotic gene BAX and fat 268 
metabolism CPT2 gene decreased in DMSO treatments compared to control while glucose 269 
metabolism G6PD gene was increased [41].  270 
With a 0.5% v:v DMSO dose, the gene expression of SOX2, OCT4, CDX2 and SOD1 did 271 
not show differences compared to control. However, 0.75% DMSO increased SOX2 and 272 
OCT4 gene expression. These genes start to express in the 8-16 cell stage embryos, and 273 
they work closely together to maintain pluripotency in embryonic stem cells (ESC) [42, 43, 274 
44] through downstream regulation of pluripotency specific genes [45]. Investigations 275 
carried out in induced pluripotent stem cells (iPSC) and ESC have demonstrated that the 276 
over-expression of SOX2 induces them to ectoderm and mesoderm differentiation, whereas 277 
the over-expression of OCT4 induces them to mesoderm and endoderm differentiation [46, 278 
47]. On the other hand, related research has shown that DMSO associated with Activin A 279 
induces ESC to definitive endoderm differentiation through downregulation of OCT4 [48]. 280 
Then, an effect of DMSO on the modulation of the genetic expression is clearly evidenced. 281 
This increase in the gene expression of SOX2 and OCT4 can be attributed to an effect of 282 
DMSO on the epigenome [49]. It has been shown that DMSO upregulates Dnmt3as, which 283 
causes de novo hypermethylation of both genic and no genic regions [50].  284 
Although oxidative stress generates global damage in the cell, the main targets of ROS are 285 
proteins, plasma membrane and DNA [11]. In this research, 0.5% v:v DMSO showed 286 
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antioxidant effects during COCs maturation as well as in blastocyst stage. Oxidative stress 287 
induced by in vitro maturation of COCs was reflected in the increase of lipid peroxidation 288 
in matured control compared to immature COCs. This increase was prevented by the use of 289 
DMSO, resulting in similar levels of lipid peroxidation in matured DMSO compared to 290 
immature COCs. Similarly, lipid peroxidation decreas d in DMSO blastocysts compared to 291 
control. Usually, during in vitro cell culture, ROS are accumulated. This generates lipid 292 
peroxidation of the membranes, the most important co sequence and indicator of oxidative 293 
stress, which amplifies the initial damage by a chain reaction [51, 52, 53, 54]. The 294 
supplementation with antioxidant compounds such as Se or alpha linoleic acid reduces 295 
membrane damage [55, 57]. However, DMSO used at higher concentrations in this work, 296 
and below 15% v:v, has shown disorders in the membrane, such as lateral expansion, 297 
undulations and concurrent drops and membrane thickness [29, 30].  298 
In oocytes, GSH synthesis decreases during maturation [57]. This tripeptide possesses a 299 
great antioxidant capacity since it oxidizes itself in a reaction mediated by glutathione 300 
peroxidase (GPX), and it reduces the environment [58]. Our results agree with this, and its 301 
effect could be related to the increase observed in lipid peroxidation. In oocytes, GSH could 302 
be raised to high levels through the supplementation in the maturation medium with β-303 
mercaptoethanol, Cysteamine and Cystine, which has been associated to a greater 304 
development of bovine embryos [59, 14, 60, 22, 20].It is remarkable that the homogenates 305 
used in this work to measure oxidant/antioxidant sta us were obtained from entire COCs. 306 
Given this, we cannot compare our results to those reported in denuded oocytes. The 307 
antioxidant effect of 0.5% DMSO on blastocysts that we observed in lipid peroxidation 308 
could also be related to total GSH concentrations, which showed an increase with DMSO 309 
treatment.  Hence, we can affirm that this effect seen in blastocysts is induced by the 310 
maturation with DMSO. On other hand, SOD protein activity did not change between the 311 
development stages or treatments. However, the SOD1 mRNA expression was also 312 
unaffected by DMSO. Alike reported by others authors, a relation between protein activity 313 
and mRNA abundance was observed [61]. 314 
In this research, DMSO matured oocytes and their resulting blastocysts exhibited lower 315 
membrane damage and higher cell number. Despite this, no differences in DNA 316 
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fragmentation between treatments were observed. This disagrees with authors who report 317 
apoptosis triggered with high concentrations as those used in this work [6]. Apoptosis 318 
induced by DMSO occurs through the permeabilization of the mitochondrial membrane by 319 
Bax and, consequently, AIF translocates to the nucleus [7]. Once there, AIF condenses the 320 
chromatin and generates DNA fragments of high molecular weight (50 bp) [62]. Then, its 321 
fragments ends can be amplified by terminal desxynocleotidyl transferase using 322 
nitrogenous bases labeled with fluorochromes and, subsequently, be identified by 323 
fluorescence microscopy [60]. The total cells number observed in DMSO treatments were 324 
similar to the results shown in control IVF embryos [61]. Nevertheless, the amount of 325 
TUNEL positive cells was equal or greater than repoted [65, 66, 67, 40]. 326 
5. Conclusions 327 
In conclusion, our results suggest that low DMSO concentrations used during bovine 328 
oocytes in vitro maturation increases the maturation, as well as the blastocyst rate and its 329 
quality, without demonstrating deleterious effect on embryo cells. 330 
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Figure 1. Schematic description of the methodology used to study the effect of the use of 556 
DMSO during maturation on embryo development and quality. IVM, In vitro maturation; 557 
IVF, In vitro fertilization; IVC, In vitro culture. 558 
 559 
 560 
Figure 2. Adjustment curve and confidence interval for the average response on values of 561 




Figure 3. Expression level of OCT4, SOX2, CDX2 and SOD1 genes in bovine blastocyst 565 
produced from oocytes supplemented with 0, 0.5 and 0.75% v:v DMSO during IVM. All 566 
genes were normalized with the ACTB gene. a, b Significant differences was observed for 567 
OCT4 and SOX2 expression in blastocyst from 0.75% v:v DMSO group (ANOVA, Tukey 568 
test p<0.05) 569 
 570 
 571 





Figure 4. SOD activity, total GSH and lipid peroxidation in immature and mature oocytes, 574 
8/16 embryos and blastocyst from oocytes supplemented with 0 and 0.5% v:v DMSO 575 
during IVM.  I: immature oocytes; CM: mature control ocytes; DM: DMSO mature 576 
oocytes; C8/16: control 8/16 cells embryos; D8/16: DMSO 8/16 cells embryos; CB; control 577 
blastocyst and DB: DMSO blastocyst. a, b Significant differences were observed in Lipid 578 






















































































































































Figure 5. TUNEL assay in blastocyst from oocytes matured with 0, 0.5 and 0.75% v:v 582 
DMSO. TUNEL positive cells were labeled with fluoresc in-12-dUTP (green), and nuclei 583 
are counterstained with DAPI (blue).  584 
 585 






































F: 5´-GGAGAGCATGTTCCTGCAGTGC 3´ 58 95 NM_174580 
R: 5´-ACACTCGGACCACGTCCTTCTC 3´ 
SOX2 
F: 5´-CGAGTGGAAACTTTTGTCCG 3´ 
55 101 
NM_00110546
3 R: 5´-GGTATTTATAATCCGGGTGTT 3´ 
CDX2 
F: 5´-CCTGTGCGAGTGGATGCGGAAG 3´ 
58 230 XM_871005 
R: 5´-CCTTTGCTCTGCGGTTCT 3´ 
SOD1 
F: 5´-CCATCCACTTCGAGGCAAAG 3´ 
58 100 NM_174615.2 
R: 5´-TCTCCAAACTGATGGACGTGG 3´ 
ACTB 
F: 5´-GGCCAACCGTGAGAAGATGACC 3´ 
58 96 BT030480.1 




First polar body extrusion in oocytes matured with different DMSO concentrations 
% DMSO  N Polar Body extrusion (%) 
0 241 178 (73.9)b 
0.1 195 143 (73.3)b 
0.5 142 135 (95.1)a 
1 192 127 (66.1)b 
10 172 13 (7.6)c 







Blastocyst rates obtained from oocytes matured withdifferent DMSO concentrations    
DMSO %  N Cleavege (%) Blastocyst (%) 
0 446 334 (74.9)ª 117 (26.2)
b 
0.1 322 248 (77.2)ª 117 (36.6)ab 
0.5 194 153 (78.9)ª 80 (41.2)ª 
1 250 193 (77.0)ª 58 (23.2)
b 
10 39 1 (2.6)b 0 (0)c 
Within a column, values with a different superscript (a or b) differed (Chi square test, p< 0.05). 
  593 
 594 
Table 4    
TUNEL positive cells in blastocysts obtained from oocytes matured with 0, 0.5 or 0.75 % 
v:v DMSO  
DMSO % N Nº Cells±SD TUNEL±SD (%) 
0 8 71±35b 10±6 (14.1) 
0.5 7 110±25a 19±5 (18.2) 
0.75 14 98±23a 18±6 (19.7) 
Within a column, values with a different superscript (a or b) differed (ANOVA and Chi square test, 
p< 0.05). 
 595 
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Highlights: 
 
• Bovine oocytes were matured with different DMSO concentrations (0, 0.1, 0.5, 1 
and 10% v:v) followed by in vitro fertilization. The optimal concentration of DMSO 
to use in the maturation was estimated in around 0.45% v:v.  
• DMSO at 0.5% v:v concentration has not effect on mRNA abundance of genes 
explored. However 0.75% v:v DMSO increased gene expression of OCT4 and 
SOX2. 
• Oocytes matured with 0.5% v:v DMSO showed reduced lipid peroxidation and 
increased glutathione. 
• Low DMSO concentrations used during in vitro maturation of bovine oocytes 
increases the maturation, as well as the blastocyst rate and its quality without any 
deleterious effect on embryo cells.  
 
 
